Screening for human immunodeficiency virus.
Screening for human immunodeficiency virus (HIV) antibodies as a means of preventing both the progress and spread of acquired immunodeficiency syndrome (AIDS) is problematic in terms of efficacy, effectiveness, and ethics. The few desired effects are mostly offset by greater and more certain undesirable effects on individuals and society.
Berlin Science Center for Social Research (WZB).
R D
RD
Rosenbrock
D015492:AIDS Serodiagnosis; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D006801:Humans; D037141:Mandatory Programs; D008403:Mass Screening / Q000592:standards*; D011237:Predictive Value of Tests; D011291:Premarital Examinations; D040841:Resource Allocation; D018570:Risk Assessment; D013673:Technology Assessment, Biomedical; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D035141:Voluntary Programs